Deal
ABBOTT LABORATORIES acquires Bigfoot Biomedical, Inc.
September 2023
Full acquisition
Ready
01 Scorecard
The deal at a glance
Private-market deal
ABBOTT LABORATORIES acquires Bigfoot Biomedical, Inc.
Deal value
(not disclosed)
Sector
Medical devices — diabetes care
Date
September 2023
VectorShift
Made on VectorShift
ABBOTT LABORATORIES acquired Bigfoot Biomedical, Inc., a transaction completed in September 2023.
Bigfoot Biomedical, Inc. operates in Medical devices — diabetes care, is based in Milpitas, California, USA. Bigfoot Biomedical develops connected insulin-management solutions, furthering Abbott's efforts to develop connected solutions for making diabetes management more personal and precise.
Furthers Abbott's efforts to develop connected solutions for making diabetes management more personal and precise.
Connected insulin-management technology that complements Abbott's FreeStyle Libre diabetes franchise. Integrated into Abbott's Diabetes Care business
On September 22, 2023, Abbott completed the acquisition of Bigfoot Biomedical, Inc. (Bigfoot), which will further Abbott's efforts to develop connected solutions for making diabetes management more personal and precise.
Abbott FY2023 10-K, Item 1 Business
Advisors not disclosed
No advisory firms have been disclosed for this transaction.